Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: A long-term follow-up study

Clinical and Experimental Rheumatology

Volumn 32, Issue 2, 2014, Pages 188-193

  Taborda, Ana L ^a   Azevedo, Pedro Correia ^b   Isenberg, David A ^c  

^a Centro Hospitalar Barreiro Montijo   (Portugal)

^b HOSPITAL GARCIA DE ORTA   (Portugal)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Dermatomyositis; Idiopathic inflammatory myopathies outcome; Long term follow up; Polymyositis

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

ADOLESCENT; ADULT; ADULT ONSET DERMATOMYOSITIS; ADULT ONSET POLYMYOSITIS; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; GENDER; HUMAN; INFECTION; JUVENILE DERMATOMYOSITIS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOSITIS; NEOPLASM; OBSERVATIONAL STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RISK FACTOR; UNITED KINGDOM; CLINICAL FEATURE; DRUG EFFECT; OUTCOME ASSESSMENT; PRESCRIPTION; PROGNOSIS; REMISSION; SEX RATIO; SURVIVAL TIME;

ADULT; AGE OF ONSET; ANTIRHEUMATIC AGENTS; AUTOANTIBODIES; CREATINE KINASE; DELAYED DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONDON; MALE; MIDDLE AGED; MYOSITIS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84904731504     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. DALAKAS MC: Review: an update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011; 37: 226-42.
2. KHAN S, CHRISTOPHER-STINE L: Polymyositis, dermatomyositis and autoimmune necrotizing myopathy: clinical features. Rheum Dis Clin North Am 2011; 37: 143-58.
3. SCHIOPU E, PHILLIPS K, MacDONALD PM, CROFFORD LJ, SOMERS EC: Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 2012; 14: R22.
4. CHEVREL G, GOEBELS N, HOHLFELD R: Myositis diagnosis and management. Practical Neurology 2002 February; 4-11.
5. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
6. BOHAN A, PETER JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
7. LINKLATER H, PIPITONE N, ROSE MR et al.: Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 2013; 31: 767-9.
8. BRONNER IM, van der MEULEN MFG, de VISSER M et al.: Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006; 65: 1456-61.
9. ANDRÁS C, PONYI A, CONSTANTIN T et al.: Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008; 35: 438-44.
10. KUO CF, SEE LC, YU KH et al.: Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 2011; 165: 1273-9.
11. MARIE I, LAHAXE L, BENVENISTE O et al.: Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 2010; 162: 337-44.
12. YU KH, WU YJJ, KUO CF et al.: Survival analysis of patients with Dermatomyositis and Polymyositis: analysis of 192 Chinese cases. Clin Rheumatol 2011; 30: 1595-601.
13. ZONG M, LUNDBERG IE: Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheum 2011; 7: 297-306.
14. DANKÓ K, PONYI A, CONSTANTIN T, BORGULYA G, SZEGEDI G: Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 2004; 83: 35-42.
15. MARIE I: Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 2012; 14: 275-85.
16. MARIE I, HATRON PY, DOMINIQUE S et al.: Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011; 63: 3439-47.
17. DIMACHKIE MM, BAROHN RJ: Inclusion Body Myositis. Seminars in Neurology, vol. 32, no.3/2012: 237-45.
18. KATZAP E, BARILLA-LaBARCA ML, MARDER G: Antisynthetase syndrome. Curr Rheumatol Rep 2011; 13: 175-81.
19. DALAKAS MC, HOHFELD R: Polymyositis and dermatomyositis. Lancet 2003; 362: 971-82.
20. MAMMEN A: Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 2011; 7: 343-54.
21. DALAKAS MC: Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2006; 2: 219-27.
22. CASTRO C, GOURLEY M: Diagnosis and treatment of inflammatory myopathy: issues and management. Ther Adv Musculoskelet Dis 2011; 4: 111-20.
23. MIRÓ O, LAGUNO M, ALONSO JR et al.: Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors. Med Clin (Barc). 1999; 24; 112: 521-6.
24. AIRIO A, KAUTIAINEN H, HAKALA M: Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006; 25: 234-9.
25. SANTO AH, SOUZA JMP, PINHEIRO CS, SOUZA DCC, SATO EI: Trends in Dermatomyositisand Polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis. BMC Public Health 2010; 10: 597-610.
26. MARIE I, HATRON PY, LEVESQUE H et al.: Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 1999; 78: 139-47.
27. MARIE I, HACHULLA E, HATRON PY et al.: Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatology 2001; 28: 2230-7.
28. FUDMAN EJ, SCHNITZER TJ: Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986; 80: 329-32.
29. LADD PE, EMERY KH, SALISBURY SR et al.: Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome. Am J Roentgenol 2011; 197: w153-8
30. SALVADOR FB, ISENBERG DA: Outcome predictors in patients with idiopathic inflammatory myopathies. Clin Exp Rheumatol 2012; 30: 980.